Core Insights - Kraig Biocraft Laboratories is advancing towards commercial-scale production of biodegradable spider silk derived from transgenic silkworms, targeting an output of 10 metric tons per month by March 2026 [1][4]. Company Development - The company has successfully integrated spider DNA into silkworms, producing recombinant spider silk fibers with strength comparable to native spider silk, and confirmed stable integration through breeding [2][3]. - Kraig Labs operates three production facilities in Vietnam and is deploying approximately one million proprietary spider silk silkworm eggs across its network [4]. Production and Orders - Kraig Labs is building inventory to fulfill orders from globally recognized brands, with initial shipments expected once material preparation is complete [5]. - The company is positioned to become the second in history to achieve commercial-scale output from a transgenic animal platform, focusing on naturally spun, biodegradable structural fibers [7]. Historical Context - The only historical precedent in transgenic animal biotechnology is the commercialization of ATryn, which took over two decades to achieve, highlighting the significance of Kraig Labs' current advancements [9][10][11]. Market Expectations - Investor attention is building around the company's engagements with three major brands, including a luxury fashion house and a performance sportswear company, with expectations for initial deliveries as production ramps up [17][18].
24/7 Market News- It’s Not Synthetic, It’s Real. Kraig Labs Nears Spider Silk Breakthrough
Globenewswire·2026-02-18 13:45